Institut für Medizininformatik, Biometrie und Epidemiologie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The Garment Protection Factor: further advances in labelling sun-protective clothing (2018) Gefeller O Journal article Signal regression models for location, scale and shape with an application to stock returns (2018) Brockhaus S, Fuest A, Mayr A, Greven S Journal article Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder (2018) Musil R, Seemueller F, Meyer S, Spellmann I, Adli M, Bauer M, Kronmueller KT, et al. Journal article Self-testing for contact allergy to hair dyes - a 5-year follow-up multicentre study (2018) Friis UF, Goosens A, Gimenez-Arnau AM, Liden C, Gimenez-Arnau E, White IR, Alfonso JH, et al. Journal article Impact of voxel size and scan time on the accuracy of three-dimensional radiological imaging data from cone-beam computed tomography (2018) Dach E, Bergauer B, Seidel A, von Wilmowsky C, Adler W, Lell M, Wichmann M, Matta RE Journal article Whole-Body Electromyostimulation combined with personalized Nutritional Support improves the Body Composition of Patients with advanced Cancer (2018) Schink K, Herrmann HJ, Schwappacher R, Orlemann T, Meyer J, Waldmann E, Wullich B, et al. Conference contribution Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (2018) Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé BE, Knieling F, et al. Journal article Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial (2018) Schink K, Herrmann HJ, Schwappacher R, Meyer J, Orlemann T, Waldmann E, Wullich B, et al. Journal article Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018) Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al. Conference contribution Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018) Gaß P, Lux MP, Rauh C, Hein A, Bani M, Fießler C, Hartmann A, et al. Journal article